tesamorelin / ipamorelin injection 2X Blend: 10mg + 2mg Tesamorelin vs. Ipamorelin | A

The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: a target for new therapies against cardiovascular diseases

Selenium nanoparticles: a review on synthesis and biomedical applications

In the Phase Ib dose escalation study (NCT02205398), 6 out of 13 c-MET positive mCRC patients whose tumors have become resistant to anti-EGFR treatment treated with capmatinib plus cetuximab achieved stable disease (disease control rate (DCR) of 46.2%) (Delord et al., 2020)

increase GSH in the brain of rats) and apoptosis (decrease Bax, increase Bcl2), inducing improvement of the acetylcholinesterase activity, modulating antioxidant enzymes gene transcripts, and decreasing body weight